The Journal of Practical Medicine >

2023 , Vol. 39 >Issue 5: 544 - 549

DOI: https://doi.org/10.3969/j.issn.1006⁃5725.2023.05.004

Special topic written talk

Research progress in the pathology and treatment of large cell lung carcinoma

Expand
  • Department of Respiratory and Critical Care Medicine，the First Affiliated Hospital of Kunming Medical University，Kunming 650000，China 

Online published: 2023-03-10

Supported by



Fold

Abstract

Large cell lung carcinoma（LCLC）is an undifferentiated non⁃small cell lung cancer that lacks the morphological and immunological markers of adenocarcinoma，squamous cell carcinoma，and small cell carci⁃ noma. LCLC has a low incidence and poor prognosis. The incidence of LCLC is less than 1% of lung cancer surgical specimens. Systemic comprehensive treatment is the main treatment. This article reviews the research progress in the pathological diagnosis and treatment of LCLC in recent years，aiming to provide a reference for further research and treatment.

Key words：

large cell carcinoma

; lung; diagnosis; treatment

Cite this article

YANG Yang, ZHANG Zhiyuan, FU Weiping. . Research progress in the pathology and treatment of large cell lung carcinoma[J]. The Journal of Practical Medicine, 2023 , 39(5) : 544 -549 . DOI: 10.3969/j.issn.1006⁃5725.2023.05.004

Options
Outlines

/

〈 〉